Pattern recognition receptors as therapeutic targets for bacterial, viral and fungal sepsis

International Immunopharmacology - Tập 98 - Trang 107909 - 2021
Koichi Yuki1, Sophia Koutsogiannaki1
1Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children’s Hospital, Department of Anaesthesia, Harvard Medical School, Department of Immunology, Harvard Medical School, United States

Tài liệu tham khảo

Eissa, 2010, Anaesthetic management of patients with severe sepsis, Br. J. Anaesth., 105, 734, 10.1093/bja/aeq305 Koutsogiannaki, 2017, From the Cover: Prolonged Exposure to Volatile Anesthetic Isoflurane Worsens the Outcome of Polymicrobial Abdominal Sepsis, Toxicol. Sci., 156, 402 Singer, 2016, The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA, 315, 801, 10.1001/jama.2016.0287 Lin, 2018, Epidemiology and Immune Pathogenesis of Viral Sepsis, Front. Immunol., 9, 2147, 10.3389/fimmu.2018.02147 Zahar, 2011, Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality, Crit. Care Med., 39, 1886, 10.1097/CCM.0b013e31821b827c Blanco, 2008, Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study, Crit. Care, 12, R158, 10.1186/cc7157 Choi, 2012, Viral infection in patients with severe pneumonia requiring intensive care unit admission, Am. J. Respir. Crit. Care Med., 186, 325, 10.1164/rccm.201112-2240OC Kumar, 2013, Recognition of bacterial infection by innate immune sensors, Crit. Rev. Microbiol., 39, 229, 10.3109/1040841X.2012.706249 Mayr, 2014, Epidemiology of severe sepsis, Virulence, 5, 4, 10.4161/viru.27372 Vincent, 2009, International study of the prevalence and outcomes of infection in intensive care units, JAMA, 302, 2323, 10.1001/jama.2009.1754 Medzhitov, 2001, Toll-like receptors and innate immunity, Nat. Rev. Immunol., 1, 135, 10.1038/35100529 Flo, 2001, Differential expression of Toll-like receptor 2 in human cells, J. Leukoc. Biol., 69, 474, 10.1189/jlb.69.3.474 Oliveira-Nascimento, 2012, The Role of TLR2 in Infection and Immunity, Front. Immunol., 3, 79, 10.3389/fimmu.2012.00079 Vaure, 2014, A comparative review of toll-like receptor 4 expression and functionality in different animal species, Front. Immunol., 5, 316, 10.3389/fimmu.2014.00316 Ramos, 2004, Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa, Trends Microbiol., 12, 509, 10.1016/j.tim.2004.09.002 Hayashi, 2001, The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, 410, 1099, 10.1038/35074106 Eaton-Bassiri, 2004, Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells, Infect. Immun., 72, 7202, 10.1128/IAI.72.12.7202-7211.2004 Strober, 2006, Signalling pathways and molecular interactions of NOD1 and NOD2, Nat. Rev. Immunol., 6, 9, 10.1038/nri1747 Inohara, 2003, NODs: intracellular proteins involved in inflammation and apoptosis, Nat. Rev. Immunol., 3, 371, 10.1038/nri1086 Zhou, 2018, Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection, Front. Immunol., 9, 3082, 10.3389/fimmu.2018.03082 van der Poll, 2017, The immunopathology of sepsis and potential therapeutic targets, Nat. Rev. Immunol., 17, 407, 10.1038/nri.2017.36 Rittirsch, 2009, Immunodesign of experimental sepsis by cecal ligation and puncture, Nat. Protoc., 4, 31, 10.1038/nprot.2008.214 Alves-Filho, 2009, Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis, Proc. Natl. Acad. Sci. U S A, 106, 4018, 10.1073/pnas.0900196106 Zou, 2011, Nonhematopoietic toll-like receptor 2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis, Shock, 36, 370, 10.1097/SHK.0b013e3182279868 Zou, 2010, Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis, Crit. Care Med., 38, 1335, 10.1097/CCM.0b013e3181d99e67 Hoshino, 1999, Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product, J. Immunol., 162, 3749, 10.4049/jimmunol.162.7.3749 Roger, 2009, Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4, Proc. Natl. Acad. Sci. U S A, 106, 2348, 10.1073/pnas.0808146106 Lorenz, 2002, Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population, Pediatr. Res., 52, 373, 10.1203/00006450-200209000-00011 Opal, 1999, Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock, J. Infect. Dis., 180, 1584, 10.1086/315093 Marshall, 2004, Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study, J. Infect. Dis., 190, 527, 10.1086/422254 Deng, 2013, Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis, J. Immunol., 190, 5152, 10.4049/jimmunol.1300496 Andonegui, 2003, Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs, J Clin Invest, 111, 1011, 10.1172/JCI16510 Alves-Filho, 2006, Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis, Crit. Care Med., 34, 461, 10.1097/01.CCM.0000198527.71819.E1 Yang, 2019, Flagellin attenuates experimental sepsis in a macrophage-dependent manner, Crit. Care, 23, 106, 10.1186/s13054-019-2408-7 Xiao, 2015, Over-activation of TLR5 signaling by high-dose flagellin induces liver injury in mice, Cell. Mol. Immunol., 12, 729, 10.1038/cmi.2014.110 Plitas, 2008, Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis, J. Exp. Med., 205, 1277, 10.1084/jem.20080162 Albiger, 2007, Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection, Cell. Microbiol., 9, 633, 10.1111/j.1462-5822.2006.00814.x Feng, 2011, MyD88 and Trif signaling play distinct roles in cardiac dysfunction and mortality during endotoxin shock and polymicrobial sepsis, Anesthesiology, 115, 555, 10.1097/ALN.0b013e31822a22f7 Sonego, 2014, MyD88-, but not Nod1- and/or Nod2-deficient mice, show increased susceptibility to polymicrobial sepsis due to impaired local inflammatory response, PLoS ONE, 9, 10.1371/journal.pone.0103734 Nunez, 2011, Intracellular sensors of microbes and danger, Immunol. Rev., 243, 5, 10.1111/j.1600-065X.2011.01058.x Deshmukh, 2009, Critical role of NOD2 in regulating the immune response to Staphylococcus aureus, Infect. Immun., 77, 1376, 10.1128/IAI.00940-08 Tidswell, 2010, Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis, Crit. Care Med., 38, 72, 10.1097/CCM.0b013e3181b07b78 Opal, 2013, Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial, JAMA, 309, 1154, 10.1001/jama.2013.2194 Skjesol, 2019, The TLR4 adaptor TRAM controls the phagocytosis of Gram-negative bacteria by interacting with the Rab11-family interacting protein 2, PLoS Pathog., 15, 10.1371/journal.ppat.1007684 Kawai, 2007, Signaling to NF-kappaB by Toll-like receptors, Trends Mol. Med., 13, 460, 10.1016/j.molmed.2007.09.002 Moreno, 2013, Therapeutic targeting of NOD1 receptors, Br. J. Pharmacol., 170, 475, 10.1111/bph.12300 Fritz, 2007, Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity, Immunity, 26, 445, 10.1016/j.immuni.2007.03.009 Lionakis, 2018, Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts, Annu. Rev. Immunol., 36, 157, 10.1146/annurev-immunol-042617-053318 Templeton, 2018, Editorial: Immunity to Human Fungal Pathogens: Mechanisms of Host Recognition, Protection, Pathology, and Fungal Interference, Front. Immunol., 9, 2337, 10.3389/fimmu.2018.02337 Richardson, 2008, Changing epidemiology of systemic fungal infections, Clin. Microbiol. Infect., 14, 5, 10.1111/j.1469-0691.2008.01978.x Delaloye, 2014, Invasive candidiasis as a cause of sepsis in the critically ill patient, Virulence, 5, 161, 10.4161/viru.26187 Kullberg, 2015, Invasive Candidiasis, N. Engl. J. Med., 373, 1445, 10.1056/NEJMra1315399 Calderone, 1991, Adherence and receptor relationships of Candida albicans, Microbiol. Rev., 55, 1, 10.1128/mr.55.1.1-20.1991 Netea, 2006, Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors, J Clin Invest, 116, 1642, 10.1172/JCI27114 Jouault, 2003, Candida albicans phospholipomannan is sensed through toll-like receptors, J. Infect. Dis., 188, 165, 10.1086/375784 Romani, 1997, An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis, J. Immunol., 158, 2356, 10.4049/jimmunol.158.5.2356 Casadevall, 2012, Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases, Cell Host Microbe, 11, 447, 10.1016/j.chom.2012.04.004 Poltorak, 1998, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, 282, 2085, 10.1126/science.282.5396.2085 Netea, 2002, The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis, J. Infect. Dis., 185, 1483, 10.1086/340511 Netea, 2004, Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells, J. Immunol., 172, 3712, 10.4049/jimmunol.172.6.3712 Villamon, 2004, Toll-like receptor-2 is essential in murine defenses against Candida albicans infections, Microbes Infect., 6, 1, 10.1016/j.micinf.2003.09.020 Bellocchio, 2004, The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo, J. Immunol., 172, 3059, 10.4049/jimmunol.172.5.3059 Sancho, 2012, Signaling by myeloid C-type lectin receptors in immunity and homeostasis, Annu. Rev. Immunol., 30, 491, 10.1146/annurev-immunol-031210-101352 Zelensky, 2005, The C-type lectin-like domain superfamily, FEBS J., 272, 6179, 10.1111/j.1742-4658.2005.05031.x Tang, 2018, Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity, Front. Immunol., 9, 123, 10.3389/fimmu.2018.00123 Li, 2011, The beta-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance, Cell Host Microbe, 10, 603, 10.1016/j.chom.2011.10.009 Taylor, 2007, Dectin-1 is required for beta-glucan recognition and control of fungal infection, Nat. Immunol., 8, 31, 10.1038/ni1408 Bi, 2010, CARD9 mediates dectin-2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans, J. Biol. Chem., 285, 25969, 10.1074/jbc.M110.131300 Ifrim, 2016, The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis, J. Interferon Cytokine Res., 36, 267, 10.1089/jir.2015.0040 Zhu, 2013, C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection, Immunity, 39, 324, 10.1016/j.immuni.2013.05.017 Plantinga, 2009, Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients, Clin. Infect. Dis., 49, 724, 10.1086/604714 Usluogullari, 2014, The role of Human Dectin-1 Y238X Gene Polymorphism in recurrent vulvovaginal candidiasis infections, Mol. Biol. Rep., 41, 6763, 10.1007/s11033-014-3562-2 Wirnsberger, 2016, Inhibition of CBLB protects from lethal Candida albicans sepsis, Nat. Med., 22, 915, 10.1038/nm.4134 Xiao, 2016, Targeting CBLB as a potential therapeutic approach for disseminated candidiasis, Nat. Med., 22, 906, 10.1038/nm.4141 Dolin, 2019, Characterization of Pathogenic Sepsis Etiologies and Patient Profiles: A Novel Approach to Triage and Treatment, Microbiol Insights, 12, 10.1177/1178636118825081 Phua, 2013, Characteristics and outcomes of culture-negative versus culture-positive severe sepsis, Crit. Care, 17, R202, 10.1186/cc12896 Li, 2020, SARS-CoV-2 and viral sepsis: observations and hypotheses, Lancet, 395, 1517, 10.1016/S0140-6736(20)30920-X Yuki, 2020, COVID-19 pathophysiology: A review, Clin. Immunol., 215, 10.1016/j.clim.2020.108427 Stetson, 2006, Type I interferons in host defense, Immunity, 25, 373, 10.1016/j.immuni.2006.08.007 Shane, 2017, Neonatal sepsis, Lancet, 390, 1770, 10.1016/S0140-6736(17)31002-4 Ding, 2017, TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury, Sci. Rep., 7, 34278, 10.1038/srep34278 Larange, 2009, TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation, J. Leukoc. Biol., 85, 673, 10.1189/jlb.0808504 Lund, 2003, Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells, J. Exp. Med., 198, 513, 10.1084/jem.20030162 Sorensen, 2008, TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain, J. Immunol., 181, 8604, 10.4049/jimmunol.181.12.8604 Pang, 2013, Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I, Proc. Natl. Acad. Sci. U S A, 110, 13910, 10.1073/pnas.1303275110 Yong, 2018, RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections, Front. Immunol., 9, 1379, 10.3389/fimmu.2018.01379 Carty, 2010, Recent insights into the role of Toll-like receptors in viral infection, Clin. Exp. Immunol., 161, 397, 10.1111/j.1365-2249.2010.04196.x